Clinical Trials in New York

Showing 7501-7520 of 22,668 trials

A Study of NT 201 Doses in the Treatment of Platysma Prominence

NCT05773053

The purpose of this study is to assess the safety and efficacy of NT 201 in adults with moderate to severe platysma prominence.

Platysma Prominence

Merz Aesthetics GmbH73 participantsStarted Mar 2023

Washington D.C., District of Columbia, United States • Aventura, Florida, United States • Coral Gables, Florida, United States +4 more locations

COMPLETEDPhase 2< 1 mile

Cytomegalovirus (CMV) Vaccine in Donors and Recipients Undergoing Allogeneic Hematopoietic Cell Transplant (HCT)

NCT00285259

The purpose of this trial is to evaluate a CMV vaccine given to related donor/recipient pairs (donors prior to peripheral blood stem cell donation and CMV-seropositive recipients just before and after transplantation) and CMV-seropositive recipient-only subjects (related or unrelated) to determine incidence rates of CMV infection, disease, and other complications from immunosuppression and/or transplantation. The outcomes for the groups receiving CMV vaccine will be compared to the outcomes for the group that received the placebo vaccine to see if there is a clinical benefit. For this trial, donors and recipients must have matched HLA genotype (matched at 5/6 or 6/6 HLA loci).

Acute Lymphoblastic LeukemiaChronic Myelogenous LeukemiaAcute Myelogenous Leukemia+3 more

Astellas Pharma Inc112 participantsStarted Jan 2006

Tucson, Arizona, United States • Duarte, California, United States • Denver, Colorado, United States +19 more locations

A Study of NT 201 Doses in the Treatment of Platysma Prominence

Cytomegalovirus (CMV) Vaccine in Donors and Recipients Undergoing Allogeneic Hematopoietic Cell Transplant (HCT)

Find Trials by Condition in New York

Study of the Safety, Pharmacokinetics and Efficacy of Tinostamustine in Patients With Advanced Solid Tumors.

Safety and Efficacy of IMC-C103C as Monotherapy and in Combination With Atezolizumab

Hypotension Prediction Index Study (HPI Study)

REVEAL 2 Trial (Evaluation of VGX-3100 and Electroporation for the Treatment of Cervical HSIL)

PK and Dose Escalation and Expansion Study of DST-2970

Milademetan in Advanced/Metastatic Solid Tumors

Impact of a Standardized Obstetrics Note Template

SL-401 as Consolidation Therapy in Patients With Adverse Risk Acute Myeloid Leukemia in First Complete Remission

Vogelxo(R) ABPM Study in Hypogandal Men

Oral FMT (Fecal Microbial Transplant) in Subjects with Multiple Sclerosis

Assessment of Macrophage Activation syndromE in STill's Disease

Anti-inflammatory Drugs and Serum Prostate-Specific Antigen Test

Bentracimab in Ticagrelor-treated Patients With Uncontrolled Bleeding or Requiring Urgent Surgery or Invasive Procedure

Study to Compare the Use of a Behavioral Health App Versus Care As Usual for 16-22 Year Olds with Depression

Feasibility of Closed-loop Automated Insulin Delivery System by Primary Care & Endocrinology, in Person & Via Telehealth

Copper Concentration & Histopathologic Changes in Liver Biopsy in Participants With Wilson Disease Treated With ALXN1840

Study Investigating the Safety and Efficacy of Blinatumomab in Combination With Pembrolizumab in Adults With Relapsed or Refractory Diffuse Large B Cell Lymphoma (DLBCL)

MK-2060 and Clopidogrel Co-administration Safety and Tolerability Study in Participants With End-Stage Renal Disease (ESRD) (MK-2060-008)